KLRS Competitors & Alternatives
Compare Kalaris Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
KLRS
Main Stock$4.05
Tradestie Score
37
Market Cap
$113.52M
Analyst Upside
+362.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$19.94
|
$170.45M | - | 41 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.40
|
$158.43M | - | 37 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.10
|
$154.27M | - | 48 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.15
|
$153.02M | - | 40 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$17.28
|
$133.50M | - | 44 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.33
|
$114.01M | - | 43 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$33.87
|
$110.20M | - | 44 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.78
|
$71.69M | - | 52 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.77
|
$71.32M | - | 38 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$11.34
|
$67.94M | - | 35 | Compare |
More KLRS Analysis
Data updated: Aug 17, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry